Financial Year |
March 31 2023 |
Monetary Funds |
566,861,606.45 |
Held-for-trading Financial Assets |
394,799,404.81 |
Notes Receivable |
466,769,798.72 |
Accounts Receivable |
1,874,352,380.80 |
Advances to Suppliers |
165,873,442.79 |
Other Receivables |
12,821,734.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,359,117,084.16 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
340,079,835.62 |
Total Current Assets |
5,255,354,084.34 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,452,926.35 |
Investment Properties |
413,337,178.21 |
Fixed Assetes |
756,315,708.86 |
Under-construction Projects |
225,971,831.65 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
419,767,110.18 |
R&D expenses |
-- |
Goodwill |
1,653,523,650.04 |
Long-Term Deferred and Prepaid Expenses |
27,605,425.41 |
Deferred Income Tax Assets |
234,230,967.66 |
Other Non-Current Assets |
73,164,987.47 |
Sub-Total of Non-Current Assets |
3,837,034,848.74 |
Total Assets |
9,092,388,933.08 |
Short-Term Loans |
926,780,192.02 |
Trading Financial liabilities |
-- |
Notes Payable |
674,223,170.57 |
Accounts Payable |
908,054,775.08 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
68,345,485.66 |
Taxes Payable |
84,589,603.26 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
77,951,741.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
89,632,897.69 |
Other Current Liabilities |
45,034,325.90 |
Sub-Total of Current Liabilities |
3,234,942,328.91 |
Long-term Loans |
683,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
56,395,811.66 |
Deferred Income Tax Liabilities |
80,122,169.29 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,081,608,295.18 |
Total Liabilities |
4,316,550,624.09 |
Paid-In Capital(Or Share Stock) |
1,675,864,589.00 |
Capital Surplus |
5,363,720,141.20 |
Surplus Reserve |
67,268,663.18 |
LESS:Treasury Stock |
200,110,014.95 |
Undistributed Profits |
-2,162,856,772.91 |
Minority Stockholder's Interest |
5,930,598.46 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,769,907,710.53 |
Owner's Equity(Stockholder's Equity) |
4,775,838,308.99 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,092,388,933.08 |